Form 8-K - Current report:
SEC Accession No. 0000950170-25-023618
Filing Date
2025-02-20
Accepted
2025-02-19 20:44:14
Documents
15
Period of Report
2025-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20250212.htm   iXBRL 8-K 53993
2 EX-10.1 cvsi-ex10_1.htm EX-10.1 341715
3 EX-10.2 cvsi-ex10_2.htm EX-10.2 126932
4 EX-10.3 cvsi-ex10_3.htm EX-10.3 255990
5 EX-10.4 cvsi-ex10_4.htm EX-10.4 64779
  Complete submission text file 0000950170-25-023618.txt   954160

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20250212.xsd EX-101.SCH 22161
18 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20250212_htm.xml XML 4003
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

EIN.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 25642884
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)